USPTO serial 79336944
LIGALLI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 30, 2024
- Examiner
- HACK, ANDREA R
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with LIGALLI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scott D. Woldow
Scott D. Woldow Smith, Gambrell & Russell, LLP1055 Thomas Jefferson Street, NWSuite 400Washington, DC 20007Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines and pharmaceutical products, preparations and substances, namely medication delivery agents in the form of liquids enabling a controlled release of active ingredients of a wide variety of pharmaceuticals | ACTIVE | — |
| 009 | Electronic readers for reading out data from vaginal diagnostic and drug delivery devices and embedded operating software therefore; downloadable software applications in the field of health measurement and drug delivery devices, namely software that delivers, tracks and captures drug and diagnostic patient data, enabling personalized patient treatment and care; downloadable software applications for storage, monitoring and control of medical data | ACTIVE | — |
| 010 | Vaginal drug and medicine delivery devices, provided empty and made in part of elastoplastic materials, comprising empty reservoirs for holding and releasing medicaments, and comprising diagnostic devices in the form of sensors, for intravaginal diagnosis and measurements; medical diagnostic devices for intravaginal diagnosis, made in part of elastoplastic materials; intravaginal drug delivery and diagnostic devices, provided empty and equipped with patient monitoring sensors; intravaginal metering pumps for delivering drugs in measured quantities for medical use, provided empty; intravaginal electro-mechanical drug delivery and diagnostic devices, provided empty; medical devices for systemic drug delivery and diagnostics that allow personalized electronic adjustments, provided empty, namely, intelligent electromechanical drug delivery and diagnostic devices equipped with sensors to be placed within the vagina; intra-vaginal apparatus for administering medication, provided empty; intra-vaginal pumps for dispensing pharmaceuticals, provided empty; vaginal diagnostic and drug delivery devices, sold empty, with integrated recorded data management software, sold as a unit | ACTIVE | — |
| 035 | Wholesale and retail store services featuring medicines and pharmaceutical products, preparations and substances, and vaginal diagnostic and drug delivery devices; collection and processing of medical data, done using automated processes, for business purposes | ACTIVE | — |
| 042 | Research and development in relation to vaginal drug and medicine delivery devices and medical diagnostic devices; research and development in the field of individual and adjustable drug delivery and intra-vaginal diagnostic devices; development of pharmaceutical preparations and medicines; information technology consulting services in relation to vaginal diagnostic and drug delivery devices; platform-as-a-service and software-as-a-service services featuring software and software platforms for tracking and capturing drug and patient data in relation to vaginal diagnostic and drug delivery devices; hosting of online platforms in relation to vaginal diagnostic and drug delivery devices; provision of scientific data in the medical sector and providing medical research insights | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LiGalli B.V.
- Other trademarks owned by LiGalli B.V.
- Other trademarks owned by LiGalli B.V.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named LIGALLI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 1, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 17, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 26, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 26, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 30, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 30, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 30, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 30, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 14, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 13, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 13, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 24, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 24, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 24, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 16, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 30, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 30, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 26, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 26, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 26, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 26, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 26, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 26, 2023 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| May 23, 2023 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| May 8, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 8, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 8, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 8, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 8, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 5, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 4, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 4, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Mar 8, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Mar 8, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 8, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 1, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 28, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 28, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 26, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 11, 2022 | RFNP | REFUSAL PROCESSED BY IB | — |
| Sep 21, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 20, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 5, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 4, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 1, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 8, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 4, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 31, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |